HEALTH HERO NETWORKS, INC. – Trademark Portfolio

Entity Type: 03

HEALTH HERO NETWORKS, INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. The owner is based in Mountain View, CA.

2570 West El Camino Real, Suite 520

Mountain View, CA 94040

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HEALTH HERO NETWORKS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does HEALTH HERO NETWORKS, INC. have?

HEALTH HERO NETWORKS, INC. has 1 U.S. trademark filed with the USPTO.

What trademark classes does HEALTH HERO NETWORKS, INC. file in?

HEALTH HERO NETWORKS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.

What is HEALTH HERO NETWORKS, INC.'s trademark registration success rate?

HEALTH HERO NETWORKS, INC. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.